Early detection of cognitive impairment is essential for improving patient outcomes, but primary care settings face significant challenges in screening. This special report summarizes key points and gaps in knowledge about methods for detecting cognitive […]
The first drugs against Alzheimer’s disease that are intended to slow down the progression of the condition will soon be authorized in Germany. On November 14, 2024, the EMA granted approval for Lecanemab in the […]
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione Policlinico Universitario A. Gemelli IRCCS have discovered that by inhibiting the brain enzyme S-acyltransferase (zDHHC) through a nasal-spray […]
A brain region affected very early in Alzheimer’s disease may explain why some aging people are at greater risk of financial exploitation. That is the key finding of our new study, published in the journal […]
A loss of brain volume associated with new immunotherapies for Alzheimer’s disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a study led by […]
Researchers have developed a cellular fractionation protocol. This method allows for precise analysis of the proteins located in synaptic membranes and in membranes outside the synapses, known as extrasynaptic membranes, in human postmortem brains.This article […]
A new neuroimaging marker of cerebral small vessel disease is related to general cognition and may serve to identify persons at risk of dementia in future clinical trials, a landmark study has found.This article was […]
The members of the Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) have announced the publication of a perspective review on the interpretability and clinical application of the Centiloid (CL) scale, a robust method for measuring […]
An estimated 13.8 million people in the U.S. will have Alzheimer’s disease (AD) by 2050, two thirds of whom are projected to be women. The brain circuitry underlying memory is widely known to differ based […]
Historical policies shaping educational attainment have enduring benefits for later life memory and risk of dementia, according to a study led by a Rutgers Health researcher.This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca